Adenocarcinoma: all 1,996 studies

Page 1 of 20. Open to participants first (369), then studies with results posted, then the rest; newest registration first within each.

• RYZ711 Diagnostic Platform StudyNot yet recruitingNCT07862582Phase 1/2
• Labyrinthin Vaccination in Veterans With Lung AdenocarcinomaNot yet recruitingNCT07859592Phase 2
• Zolbetuximab and Other Cancer Treatments in People With Advanced Gastric or GEJ Cancer in Clinical Practice (RADIANCE)Not yet recruitingNCT07858500
• Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-MakingRecruitingNCT07856017
• A Study of Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric CancerNot yet recruitingNCT07829757Phase 4
• A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal AdenocarcinomaNot yet recruitingNCT07818070Phase 3
• A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid TumorsRecruitingNCT07801508Phase 1
• A Study in Greece Observing How Patients With Stomach and Esophageal Cancer Are Diagnosed and Treated in Everyday Medical PracticeRecruitingNCT07800754
• ABCSG R07 Rectal Cancer RegistryNot yet recruitingNCT07780305
• 68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal TherapyNot yet recruitingNCT07747493Not applicable
• Study of Oral MRT-2359 With Apalutamide in Prostate CancerRecruitingNCT07745361Phase 2
• Clinical Study on Using Laparoscopic Sentinel Lymph Node Navigation Combined With Dual Endoscopy Surgery for Early Gastric CancerRecruitingNCT07708012Not applicable
• DBC-664 in Adult Patients With Solid TumorsRecruitingNCT07705035Phase 1
• Pilot Feasibility Study of a Dyadic Culinary Nutrition InterventionNot yet recruitingNCT07702864Not applicable
• Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction AdenocarcinomaRecruitingNCT07699939Phase 2
• Evaluation of Pelvic Floor Function and Psychosocial Sequelae Following Radical Prostatectomy for Prostate CancerEnrolling by invitationNCT07693647
• Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ AdenocarcinomaNot yet recruitingNCT07692334Phase 2
• Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07689292Phase 2
• A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric CancerRecruitingNCT07673887Phase 3
• Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid TumorsRecruitingNCT07628634Early Phase 1
• Prostate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScoreRecruitingNCT07617272Phase 2
• Comparative Analysis of Immunological Responses to Vitamin D Replacement Therapy in Black and West African Men Diagnosed With Prostate Cancer: Elucidating Differential Effects on Immune Function Between Patients With Localized Disease and Those With Metastatic ProgressionNot yet recruitingNCT07598032Phase 3
• A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor TherapyNot yet recruitingNCT07592910Phase 2
• Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active SurveillanceNot yet recruitingNCT07574541Phase 2
• Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1RecruitingNCT07552922Not applicable
• A Study to Evaluate the Performance of Confocal Microscopy to Detect Positive Margins During Radical ProstatectomyRecruitingNCT07541911Not applicable
• Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ AdenocarcinomaRecruitingNCT07529808Phase 1/2
• Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical ProstatectomyRecruitingNCT07516886
• Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy Using SBRT for Prostate Cancer to Reduce Treatment ToxicityNot yet recruitingNCT07515651Phase 2
• Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07507916Phase 2
• Evaluation of the Efficacy of Negative Pressure Wound Therapy on Perineal Healing Following Abdominoperineal AmputationRecruitingNCT07489820Not applicable
• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsRecruitingNCT07488676Phase 1/2
• Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in AlgeriaRecruitingNCT07484971
• PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate CancerNot yet recruitingNCT07460726
• A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of CancerNot yet recruitingNCT07455422Not applicable
• Rezvilutamide for High-Risk Prostate Cancer After SurgeryNot yet recruitingNCT07444983Not applicable
• Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate CancerEnrolling by invitationNCT07439913
• Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2RecruitingNCT07431281Phase 3
• PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate CancerRecruitingNCT07426055Phase 2/3
• ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0RecruitingNCT07407608
• Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two FractionsRecruitingNCT07391982Not applicable
• Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.RecruitingNCT07385703Phase 3
• LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.RecruitingNCT07370597
• Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix CancerNot yet recruitingNCT07368985Phase 2
• The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate CancerRecruitingNCT07363382Phase 1/2
• Adaptive Stereotactic Radiotherapy for Localized Prostate CancerRecruitingNCT07344844Not applicable
• Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & EffectivenessRecruitingNCT07339943Not applicable
• A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecRecruitingNCT07332000Phase 2
• Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate AdenocarcinomaRecruitingNCT07316686Phase 1
• REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)RecruitingNCT07302451Phase 2
• First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid TumorsRecruitingNCT07284186Phase 1
• Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal CancerRecruitingNCT07281768Phase 2
• CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate CancerNot yet recruitingNCT07268794Phase 2
• Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaRecruitingNCT07259317Phase 2
• Adaptive Radiation Boost for Rectal CancerRecruitingNCT07221058Phase 1
• Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate CancerRecruitingNCT07219303Not applicable
• A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Enrolling by invitationNCT07218003Phase 1
• 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRIRecruitingNCT07209878Phase 2/3
• Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their SpousesRecruitingNCT07196488Not applicable
• Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate CancerRecruitingNCT07182279Phase 1/2
• Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)RecruitingNCT07179783Phase 2
• Navigation, Outcomes and Quality-of-life in Prostate Cancer Patients Undergoing PSMA-targeted SurgeryRecruitingNCT07129551Not applicable
• DESTINY-PANTUMOUR04RecruitingNCT07124000
• Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years OldNot yet recruitingNCT07118800Phase 3
• A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung CancersRecruitingNCT07117214Phase 1
• PSMA PET for Surveillance After Focal TherapyRecruitingNCT07115914Not applicable
• Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric CancerRecruitingNCT07098026Not applicable
• Personalization of External Beam Radiation Therapy in Localised TumoursRecruitingNCT07047495
• The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)RecruitingNCT07038304Phase 2
• Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric CancerRecruitingNCT07026149Phase 2
• A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ AdenocarcinomaRecruitingNCT07023315Phase 3
• An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction AdenocarcinomaRecruitingNCT07018570Phase 2
• Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive MalignanciesNot yet recruitingNCT07014254Not applicable
• Evaluation of Tumor Budding In Colorectal AdenocarcinomaNot yet recruitingNCT07003776
• Prospective Data Collection Initiative on Thoracic MalignanciesRecruitingNCT06996249
• Adebrelimab With Chemoradiotherapy and Surgery for G/GEJRecruitingNCT06985602Phase 2
• The Application Value of Spectral CT in the Accurate Staging of Breast CancerNot yet recruitingNCT06977412Not applicable
• Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic ProgressionNot yet recruitingNCT06977061Phase 2/3
• Sintilimab Plus Apatinib and SOX as First-line Treatment in Patients With AFP Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT06973330Phase 2
• Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation TherapyRecruitingNCT06957691Phase 2
• A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT06944496Phase 3
• Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaNot yet recruitingNCT06942767Phase 2
• A Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety of Ivonescimab (AK112) Combined With TAS-102 in the Treatment of Refractory MSS/pMMR Advanced Colorectal CancerEnrolling by invitationNCT06936488Not applicable
• Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal AdenocarcinomaNot yet recruitingNCT06933966Phase 2
• Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon CancerEnrolling by invitationNCT06931808Phase 4
• Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT06925243Phase 3
• A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal CancerNot yet recruitingNCT06919510Phase 2
• Real-world Experience With Combination Chemotherapy and Osimertinib in Poor Prognostic Group of Metastatic EGFR-mutated Lung AdenocarcinomaNot yet recruitingNCT06918782Phase 2
• Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) TrialRecruitingNCT06915909Not applicable
• A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDACNot yet recruitingNCT06913218Phase 1
• 68Ga-FAPI-46 in Staging of Pancreatic AdenocarcinomaNot yet recruitingNCT06911021Not applicable
• A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCRecruitingNCT06908304Phase 3
• A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.RecruitingNCT06902545
• A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerRecruitingNCT06901531Phase 3
• Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic AdenocarcinomaRecruitingNCT06893536
• Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric CancerNot yet recruitingNCT06888037Phase 2
• Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the OvaryRecruitingNCT06883487
• MRD-Guided Surveillance in Operable Colon Adenocarcinoma (I-III)(SURVEILLANCE-I)Not yet recruitingNCT06879873
• RegisterPROS - A Registry for Prostate CancersEnrolling by invitationNCT06872619
• Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal CancerNot yet recruitingNCT06872606Phase 2

← Adenocarcinoma overview